Health

STAT+: BIO joins the legal fight against Medicare pilot that ties drug prices to peer countries

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 08/11/2026, 05:07:23 UTC.

Briefings

The Biotechnology Innovation Organization (BIO) and two California biotech trade groups filed a lawsuit against the Trump administration's Medicare pilot program, GLOBE, claiming it exceeds Medicare's statutory authority. The complaint seeks to halt the model, though the Centers for Medicare and Medicaid Services has not yet responded to a request for comment. This legal challenge represents a significant shift in how drug pricing is regulated within the U.S. healthcare system.

Key points

• BIO and two California biotech trade groups filed a complaint in the U.S. District Court for the Northern District of California on November 7, 2026, against the Trump administration's GLOBE pilot program.
• The lawsuit asserts that the Global Benchmark for Efficient Drug Pricing demonstration oversteps Medicare's statutory authority, prompting a request to halt the model.

Context

The Biotechnology Innovation Organization is challenging the Trump administration's pilot program to align drug prices in Medicare with prices charged in peer countries. BIO and two California-based biotech trade groups filed a complaint in the U.S. District Court for the Northern District of California asserting that the Global Benchmark for Efficient Drug Pricing demonstration, known as GLOBE, oversteps Medicare's statutory authority. The Centers for Medicare and Medicaid Services did not immediately respond to a request for comment.

Limitations

The evidence is limited to the initial complaint filed by BIO and two California biotech trade groups in the U.S. District Court for the Northern District of California on November 7, 2026. The Centers for Medicare and Medicaid Services has not yet responded to a request for comment, and the specific legal arguments or evidence presented in the complaint are not detailed in the source.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 08/11/2026, 05:09:33 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeiedkvbdvlh7pg367s6u3bcif4n4srcwv36br3hlpbcra2qnflogse